1. miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells
   Nicholas J. Monteleone et al, 2020, Oncotarget CrossRef
2. Ribosome induces transdifferentiation of A549 and H-111-TC cancer cell lines
   Mohammad Badrul Anam et al, 2021, Biochemistry and Biophysics Reports CrossRef
3. Exploring the Sensitivity of Antibody–Drug Conjugate Efficacy to the Selection of Payload, Antibody, and Cell line
   Mara Rao et al, 2024, Bioconjugate Chemistry CrossRef
4. Co-encapsulated nanoparticles of Erlotinib and Quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition
   Parimala Devi Ganthala et al, 2022, Colloids and Surfaces B: Biointerfaces CrossRef
5. Isolation and Initial Characterization of Resistant Cells to Photodynamic Therapy
   A Zamarrón et al, 2015, Resistance to Photodynamic Therapy in Cancer CrossRef
6. Organometallic–Erlotinib Conjugates Active against Lung Cancer Cells and as Emerging Virus Entry Inhibitors
   Przemysław Biegański et al, 2024, Organometallics CrossRef
7. A study of electrochemical biosensor for analysis of three-dimensional (3D) cell culture
   Se Hoon Jeong et al, 2012, Biosensors and Bioelectronics CrossRef
8. Isolation and characterization of PDT-resistant cancer cells
   Alicia Zamarrón et al, 2015, Photochemical & Photobiological Sciences CrossRef
9. 68 Ga labeled Erlotinib: A novel PET probe for imaging EGFR over-expressing tumors
   Akanksha Jain et al, 2017, Bioorganic & Medicinal Chemistry Letters CrossRef
10. Novel quinazolin‐4(3H)‐one linked to 1,2,3‐triazoles: Synthesis and anticancer activity
    Maliheh Safavi et al, 2018, Chemical Biology & Drug Design CrossRef